APA (7th ed.) Citation

ML, P., A, M., CJ, S., FG, B., H, L., JL, H., . . . CC, Z. (2026). Povorcitinib for hidradenitis suppurativa: The randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. Nature medicine. https://doi.org/10.1038/s41591-026-04534-z

Chicago Style (17th ed.) Citation

ML, Porter, et al. "Povorcitinib for Hidradenitis Suppurativa: The Randomized, Double-blind, Placebo-controlled STOP-HS1 and STOP-HS2 Phase 3 Trials." Nature Medicine 2026. https://doi.org/10.1038/s41591-026-04534-z.

MLA (9th ed.) Citation

ML, Porter, et al. "Povorcitinib for Hidradenitis Suppurativa: The Randomized, Double-blind, Placebo-controlled STOP-HS1 and STOP-HS2 Phase 3 Trials." Nature Medicine, 2026, https://doi.org/10.1038/s41591-026-04534-z.